![Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain | Science Translational Medicine Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aat8462/asset/05c823f0-a764-4468-b498-e10d4bed5d82/assets/graphic/aat8462-f1.jpeg)
Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain | Science Translational Medicine
![Exifone Is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration | ACS Chemical Neuroscience Exifone Is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00308/asset/images/large/cn0c00308_0010.jpeg)
Exifone Is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration | ACS Chemical Neuroscience
![Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization. - Abstract - Europe PMC Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7393090/bin/41598_2020_69744_Fig2_HTML.jpg)
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization. - Abstract - Europe PMC
![Pharmaceuticals | Free Full-Text | Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design Pharmaceuticals | Free Full-Text | Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-14-01062/article_deploy/html/images/pharmaceuticals-14-01062-g005.png?1634890092)